Altered lung development in bronchopulmonary dysplasia

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 100, Issue 3, 2014, Pages 158-167

  Hadchouel, Alice ^a,b,c   Franco Montoya, Marie Laure ^a   Delacourt, Christophe ^a,b,c  

^a INSERM U955   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Airway; Alveolarization; Genetics; Lung function; Metalloproteinases; Preterm; VEGF

Indexed keywords

CYTOKINE; ELASTIN; FIBROBLAST GROWTH FACTOR; MATRIX METALLOPROTEINASE;

ANGIOGENESIS; ARTICLE; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HISTOPATHOLOGY; HUMAN; LUNG DEVELOPMENT; LUNG DYSPLASIA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY FUNCTION; SIGNAL TRANSDUCTION; BRONCHOPULMONARY DYSPLASIA; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; LUNG; MALE; METABOLISM; NEWBORN; PATHOLOGY;

ANIMALIA;

BRONCHOPULMONARY DYSPLASIA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MALE;

EID: 84896494604     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23237     Document Type: Article

References (100)

1. Ambalavanan N, Novak ZE. 2003. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Pediatr Res 53:240-244.
2. Antonucci R, Contu P, Porcella A, et al. 2004. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia? J Perinat Med 32:272-277.
3. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. 2003. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 349:959-967.
4. Atkinson JJ, Holmbeck K, Yamada S, et al. 2005. Membrane-type 1 matrix metalloproteinase is required for normal alveolar development. Dev Dyn 232:1079-1090.
5. Balinotti JE, Chakr VC, Tiller C, et al. 2010. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med 181:1093-1097.
6. Baraldi E, Filippone M. 2007. Chronic lung disease after premature birth. N Engl J Med 357:1946-1955.
7. Barrington KJ, Finer N. 2010. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 12:CD000509.
8. Bellusci S, Grindley J, Emoto H, et al. 1997. Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 124:4867-4878.
9. Bhandari V, Bizzarro MJ, Shetty A, et al. 2006. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117:1901-1906.
10. Bhandari V, Choo-Wing R, Lee CG, et al. 2008. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 39:420-430.
11. Bhatt AJ, Pryhuber GS, Huyck H, et al. 2001. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164(Pt 1):1971-1980.
12. Bland RD, Xu L, Ertsey R, et al. 2007. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 292:L1370-L1384.
13. Bonikos DS, Bensch KG, Northway WH Jr, Edwards DK. 1976. Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol 7:643-666.
14. Boucherat O, Bourbon JR, Barlier-Mur AM, et al. 2007. Differential expression of matrix metalloproteinases and inhibitors in developing rat lung mesenchymal and epithelial cells. Pediatr Res 62:20-25.
15. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C. 2005. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 57:38R-46R.
16. Brettell LM, McGowan SE. 1994. Basic fibroblast growth factor decreases elastin production by neonatal rat lung fibroblasts. Am J Respir Cell Mol Biol 10:306-315.
17. Bruce MC, Bruce EN, Janiga K, Chetty A. 1993. Hyperoxic exposure of developing rat lung decreases tropoelastin mRNA levels that rebound postexposure. Am J Physiol 265(Pt 1):L293-300.
18. Bruce MC, Pawlowski R, Tomashefski JF Jr. 1989. Changes in lung elastic fiber structure and concentration associated with hyperoxic exposure in the developing rat lung. Am Rev Respir Dis 140:1067-1074.
19. Bruce MC, Wedig KE, Jentoft N, et al. 1985. Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia. Am Rev Respir Dis 131:568-572.
20. Bry K, Whitsett JA, Lappalainen U. 2007. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 36:32-42.
21. Bucher JR, Roberts RJ. 1981. The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation, and changes in antioxidant enzyme activities. Pediatr Res 15:999-1008.
22. Chailley-Heu B, Boucherat O, Barlier-Mur AM, Bourbon JR. 2005. FGF18 is up-regulated in the postnatal rat lung and enhances elastogenesis in myofibroblasts. Am J Physiol Lung Cell Mol Physiol 288:L43-L51.
23. Coalson JJ. 2003. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 8:73-81.
24. Coalson JJ. 2006. Pathology of bronchopulmonary dysplasia. Semin Perinatol 30:179-184.
25. Coalson JJ, Winter V, deLemos RA. 1995. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 152:640-646.
26. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. 1999. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160:1333-1346.
27. Compernolle V, Brusselmans K, Acker T, et al. 2002. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8:702-710.
28. Danan C, Franco M, Jarreau P, et al. 2002a. High levels of keratinocyte growth factor in airways of premature infants predicted absence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 165:1384-1387.
29. Danan C, Jarreau PH, Franco ML, et al. 2002b. Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol (Lung Cell Mol Biol) 283:L1086-L1093.
30. Fakhoury KF, Sellers C, Smith EO, et al. 2010. Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia. Pediatrics 125:e1441-e1447.
31. Fawke J, Lum S, Kirkby J, et al. 2010. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 182:237-245.
32. Franco-Montoya M, Bourbon J, Durrmeyer X, et al. 2009. Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 297:L965-L976.
33. Franco-Montoya ML, Boucherat O, Thibault C, et al. 2011. Profiling target genes of FGF18 in the postnatal mouse lung: possible relevance for alveolar development. Physiol Genomics 43:1226-1240.
34. Franco ML, Waszak P, Banalec G, et al. 2002. LPS-induced lung injury in neonatal rats: changes in gelatinase activities and consequences on lung growth. Am J Physiol Lung Cell Mol Physiol 282:L491-L500.
35. Frey G, Egli E, Chailley-Heu B, et al. 2004. Effects of mild vitamin a deficiency on lung maturation in newborn rats: a morphometric and morphologic study. Biol Neonate 86:259-268.
36. Friedrich L, Pitrez PM, Stein RT, et al. 2007. Growth rate of lung function in healthy preterm infants. Am J Respir Crit Care Med 176:1269-1273.
37. Galambos C, Ng YS, Ali A, et al. 2002. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol 27:194-203.
38. Gras-Le Guen C, Denis C, Franco-Montoya ML, et al. 2008. Antenatal infection in the rabbit impairs post-natal growth and lung alveolarisation. Eur Respir J 32:1520-1528.
39. Grover TR, Asikainen TM, Kinsella JP, et al. 2007. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs. Am J Physiol Lung Cell Mol Physiol 292:L1345-L1351.
40. Hadchouel A, Decobert F, Franco-Montoya ML, et al. 2008. Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. PLoS ONE 3:e3188.
41. Hadchouel A, Durrmeyer X, Bouzigon E, et al. 2011. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med 184:1164-1170.
42. Hilgendorff A, Reiss I, Ehrhardt H, et al. 2014. Chronic lung disease in the preterm infant: lessons learned from animal models. Am J Respir Cell Mol Biol 50:233-245.
43. Hislop AA, Wigglesworth JS, Desai R, Aber V. 1987. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev 15:147-164.
44. Hokuto I, Perl AK, Whitsett JA. 2003. Prenatal, but not postnatal, inhibition of fibroblast growth factor receptor signaling causes emphysema. J Biol Chem 278:415-421.
45. Husain AN, Siddiqui NH, Stocker JT. 1998. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29:710-717.
46. Jakkula M, Le Cras TD, Gebb S, et al. 2000. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279:L600-L607.
47. Jiang JS, Chou HC, Yeh TF, Chen CM. 2012. Maternal nicotine effects on vascular endothelial growth factor expression and morphometry in rat lungs. Early Hum Dev 88:525-529.
48. Jobe AH, Bancalari E. 2001. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729.
49. Keenaghan M, Cai CL, Kumar D, et al. 2013. Response of vascular endothelial growth factor and angiogenesis-related genes to stepwise increases in inspired oxygen in neonatal rat lungs. Pediatr Res 73:630-638.
50. Kheradmand F, Rishi K, Werb Z. 2002. Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. J Cell Sci 115:839-848.
51. Klar J, Blomstrand P, Brunmark C, et al. 2011. Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary disease. J Med Genet 48:705-709.
52. Kotecha SJ, Edwards MO, Watkins WJ, et al. 2013. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax 68:760-766.
53. Kotecha SJ, Watkins WJ, Paranjothy S, et al. 2012. Effect of late preterm birth on longitudinal lung spirometry in school age children and adolescents. Thorax 67:54-61.
54. Kumarasamy A, Schmitt I, Nave AH, et al. 2009. Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs. Am J Respir Crit Care Med 180:1239-1252.
55. Kunzmann S, Speer CP, Jobe AH, Kramer BW. 2007. Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs. Am J Physiol Lung Cell Mol Physiol 292:L223-L231.
56. Lacaze-Masmonteil T. 2014. That chorioamnionitis is a risk factor for bronchopulmonary dysplasia - the case against. Paediatr Respir Rev 15:53-55.
57. Laughon MM, Langer JC, Bose CL, et al. 2011. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med 183:1715-1722.
58. Lavoie PM, Pham C, Jang KL. 2008. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 122:479-485.
59. Le Cras TD, Spitzmiller RE, Albertine KH, et al. 2004. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 287:L134-L142.
60. Lecart C, Cayabyab R, Buckley S, et al. 2000. Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate 77:217-223.
61. Lezmi G, Verkarre V, Khen-Dunlop N, et al. 2013. FGF10 Signaling differences between type I pleuropulmonary blastoma and congenital cystic adenomatoid malformation. Orphanet J Rare Dis 8:130.
62. Liebeskind A, Srinivasan S, Kaetzel D, Bruce M. 2000. Retinoic acid stimulates immature lung fibroblast growth via a PDGF-mediated autocrine mechanism. Am J Physiol Lung Cell Mol Physiol 279:L81-L90.
63. Lindahl P, Karlsson L, Hellstrom M, et al. 1997. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development 124:3943-3953.
64. Liu B, Harvey CS, McGowan SE. 1993. Retinoic acid increases elastin in neonatal rat lung fibroblast cultures. Am J Physiol 265(Pt 1):L430-L437.
65. Lopez E, Boucherat O, Franco-Montoya ML, et al. 2006. Nitric oxide donor restores lung growth factor and receptor expression in hyperoxia-exposed rat pups. Am J Respir Cell Mol Biol 34:738-745.
66. Mahut B, De Blic J, Emond S, et al. 2007. Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function. Arch Dis Child Fetal Neonatal Ed 92:F459-F464.
67. Maki JM, Sormunen R, Lippo S, et al. 2005. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol 167:927-936.
68. Margraf LR, Tomashefski JF Jr, Bruce MC, Dahms BB. 1991. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 143:391-400.
69. Massaro GD, Massaro D. 1996. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol 270(Pt 1):L305-L310.
70. McCurnin D, Seidner S, Chang LY, et al. 2008. Ibuprofen-induced patent ductus arteriosus closure: physiologic, histologic, and biochemical effects on the premature lung. Pediatrics 121:945-956.
71. Mokres LM, Parai K, Hilgendorff A, et al. 2010. Prolonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice. Am J Physiol Lung Cell Mol Physiol 298:L23-L35.
72. Nakada M, Miyamori H, Yamashita J, Sato H. 2003. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Cancer Res 63:3364-3369.
73. Nakanishi H, Sugiura T, Streisand JB, et al. 2007. TGF-beta-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. Am J Physiol Lung Cell Mol Physiol 293:L151-L161.
74. Northway WH Jr, Rosan RC, Porter DY. 1967. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276:357-368.
75. Park HS, Park JW, Kim HJ, et al. 2013. Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by activating the hypoxia-inducible factor signaling pathway. Am J Respir Cell Mol Biol 48:105-113.
76. Powell PP, Wang CC, Horinouchi H, et al. 1998. Differential expression of fibroblast growth factor receptors 1 to 4 and ligand genes in late fetal and early postnatal rat lung. Am J Respir Cell Mol Biol 19:563-572.
77. Ramasamy SK, Mailleux AA, Gupte VV, et al. 2007. Fgf10 dosage is critical for the amplification of epithelial cell progenitors and for the formation of multiple mesenchymal lineages during lung development. Dev Biol 307:237-247.
78. Schulz CG, Sawicki G, Lemke RP, et al. 2004. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatr Res 55:794-801.
79. Shaw GM, O'Brodovich HM. 2013. Progress in understanding the genetics of bronchopulmonary dysplasia. Semin Perinatol 37:85-93.
80. Sobonya RE, Logvinoff MM, Taussig LM, Theriault A. 1982. Morphometric analysis of the lung in prolonged bronchopulmonary dysplasia. Pediatr Res 16:969-972.
81. Speer CP. 2006. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 11:354-362.
82. Stocker JT. 1986. Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants. Hum Pathol 17:943-961.
83. Tang JR, Markham NE, Lin YJ, et al. 2004. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287:L344-L351.
84. Thebaud B, Abman SH. 2007. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175:978-985.
85. Thebaud B, Ladha F, Michelakis ED, et al. 2005. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112:2477-2486.
86. Thibeault DW, Mabry SM, Ekekezie II, Truog WE. 2000. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 106:1452-1459.
87. Thibeault DW, Mabry SM, Norberg M, et al. 2004. Lung microvascular adaptation in infants with chronic lung disease. Biol Neonate 85:273-282.
88. Thomas W, Speer C. 2014. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia - the case in favour. Paediatr Respir Rev 15:49-52.
89. Vadivel A, Abozaid S, van Haaften T, et al. 2010. Adrenomedullin promotes lung angiogenesis, alveolar development, and repair. Am J Respir Cell Mol Biol 43:152-160.
90. Vadivel A, Alphonse RS, Etches N, et al. 2014. Hypoxia inducible factors promotes alveolar development and regeneration. Am J Respir Cell Mol Biol 50:96-105.
91. Vicencio AG, Lee CG, Cho SJ, et al. 2004. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31:650-656.
92. Volckaert T, Campbell A, De Langhe S. 2013. c-Myc regulates proliferation and Fgf10 expression in airway smooth muscle after airway epithelial injury in mouse. PLoS One 8:e71426.
93. Vollsaeter M, Roksund OD, Eide GE, et al. 2013. Lung function after preterm birth: development from mid-childhood to adulthood. Thorax 68:767-776.
94. Wang H, St Julien KR, Stevenson DK, et al. 2013. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics 132:290-297.
95. Warner BB, Stuart LA, Papes RA, Wispe JR. 1998. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 275(Pt 1):L110-117.
96. Weinstein M, Xu X, Ohyama K, Deng CX. 1998. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125:3615-3623.
97. Welsh L, Kirkby J, Lum S, et al. 2010. The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax 65:165-172.
98. Wendel DP, Taylor DG, Albertine KH, et al. 2000. Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol 23:320-326.
99. Xu XF, Lv Y, Gu WZ, et al. 2013. Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat: epigenetics in PAH following IUGR. Respir Res 14:20.
100. Zana-Taieb E, Butruille L, Franco-Montoya ML, et al. 2013. Effect of two models of intrauterine growth restriction on alveolarization in rat lungs: morphometric and gene expression analysis. PLoS One 8:e78326.